299 results on '"Presta, Marco"'
Search Results
2. Discovery of novel FGF trap small molecules endowed with anti-myeloma activity
3. The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
4. Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer
5. The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.
6. FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer
7. Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase
8. Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
9. β-Galactosylceramidase in cancer: friend or foe?
10. Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma
11. Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells
12. Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence
13. Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88
14. Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas
15. A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis
16. Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes
17. d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3
18. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications
19. Zebrafish disease models in hematology: Highlights on biological and translational impact
20. Dendritic cells in inflammatory angiogenesis and lymphangiogenesis
21. Long pentraxin 3: A novel multifaceted player in cancer
22. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
23. Cell Membrane GM 1 Ganglioside is a Functional Coreceptor for Fibroblast Growth Factor 2
24. Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human Melanoma.
25. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases
26. COSMOS-rice technology abrogates the biotoxic effects of municipal solid waste incinerator residues
27. Blocking the FGF/FGFR system as a ⿿two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy
28. Dataset: Impact of β-Galactosylceramidase Overexpression on the Protein Profile of Braf(V600E) Mutated Melanoma Cells.
29. Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy
30. Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance
31. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy
32. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy
33. Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology
34. Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease
35. Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors
36. Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk
37. A novel ex vivo murine retina angiogenesis (EMRA) assay
38. Ascorbic acid rescues cardiomyocyte development in Fgfr1−/− murine embryonic stem cells
39. The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells.
40. Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease
41. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone
42. Blocking the FGF/FGFR system as a “two-compartment” antiangiogenic/antitumor approach in cancer therapy
43. Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors: AN INTEGRATED STRATEGY FOR THE DEVELOPMENT OF NEW ANTIANGIOGENIC COMPOUNDS
44. Nanoliter contact angle probes tumor angiogenic ligand–receptor protein interactions
45. HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium
46. Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case
47. Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy
48. The Mitogenic Signaling Pathway but Not the Plasminogen Activator-Inducing Pathway of Basic Fibroblast Growth Factor Is Mediated through Protein Kinase C in Fetal Bovine Aortic Endothelial Cells
49. Purification of a Factor from Human Placenta That Stimulates Capillary Endothelial Cell Protease Production, DNA Synthesis, and Migration
50. A Six-Amino Acid Deletion in Basic Fibroblast Growth Factor Dissociates its Mitogenic Activity from its Plasminogen Activator-Inducing Capacity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.